Back
Reata Pharmaceuticals Quote, Financials, Valuation and Earnings

Your Chance To Invest In The Green Energy Revolution!
Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!
Buy
72
RETA
Reata Pharmaceuticals
Last Price:
42.84
Seasonality Move:
-9.52%
7 Day Trial
ALL ACCESS PASS
$
7

New Year, New Trades, Try A.I. Today
Learn to forecast trends with up to 87.4% proven accuracy -> Register HereReata Pharmaceuticals Price Quote
$42.84
+1.98 (+4.85%)
(Updated: January 27, 2023 at 12:30 PM ET)
Reata Pharmaceuticals Key Stats
Buy
72
Reata Pharmaceuticals (RETA)
is a Buy
Day range:
$38.97 - $42.49
52-week range:
$18.47 - $46.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
473.22
P/B ratio:
331.71%
Volume:
1M
Avg. volume:
556.4K
1-year change:
54.6%
Market cap:
$1.5B
Revenue:
$11.5M
EPS:
$-8.56
How Much Does Reata Pharmaceuticals Make?
-
How Much Are Reata Pharmaceuticals's Sales Annually?
RETA Revenues are $11.5M -
How Much Profit Does Reata Pharmaceuticals's Make A Year?
RETA net income is -$297.4M
Is Reata Pharmaceuticals Growing As A Company?
-
What Is Reata Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.93% -
What Is Reata Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Reata Pharmaceuticals Stock Price Performance
-
Did Reata Pharmaceuticals Stock Go Up Last Month?
Reata Pharmaceuticals share price went up by 13.5% last month -
Did RETA's Share Price Rise Over The Last Year?
RETA share price rose by 54.6% over the past 1 year
What Is Reata Pharmaceuticals 52-Week High & Low?
-
What Is Reata Pharmaceuticals’s 52-Week High Share Price?
Reata Pharmaceuticals has traded as high as $46.90 over the past 52 weeks -
What Is Reata Pharmaceuticals’s 52-Week Low Share Price?
Reata Pharmaceuticals has traded as low as $18.47 over the past 52 weeks
Reata Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Reata Pharmaceuticals?
-
How Much Debt Does Reata Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Reata Pharmaceuticals Have?
Cash and short term investments quarterly total is $435.9M -
What Is Reata Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.12
Is Reata Pharmaceuticals Cash Flow Positive?
-
What Is RETA Cash Flow From Operations?
Cash flow from operations (TTM) is -$276.8M -
What Is Reata Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.3M -
What Is Reata Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$405.9M
Reata Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
RETA return on invested capital is -242.48% -
What Is Reata Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -46.37% -
What Is RETA Return On Equity?
ROE is a measure of profitability and is -242.48%
Reata Pharmaceuticals Earnings Date & Stock Price
-
What Is Reata Pharmaceuticals's Stock Price Today?
A single share of RETA can be purchased today for 40.86 -
What Is Reata Pharmaceuticals’s Stock Symbol?
Reata Pharmaceuticals trades on the nasdaq under the ticker symbol: RETA -
When Is Reata Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Reata Pharmaceuticals is scheduled on February 28, 2023 -
When Is RETA's next ex-dividend date?
Reata Pharmaceuticals's next ex-dividend date is January 27, 2023 -
How To Buy Reata Pharmaceuticals Stock?
You can buy Reata Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Reata Pharmaceuticals Competitors
-
Who Are Reata Pharmaceuticals's Competitors?
Below is a list of companies who compete with Reata Pharmaceuticals or are related in some way:
Reata Pharmaceuticals Dividend Yield
Data Unavailable
Reata Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 28.18% |
Revenue: | -92.69% | -36.71% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 62.40 |
Upside from Last Price: | 52.72% |